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Purpose:
In the present study a phospholipid based complex of 
apigenin (APLC) was prepared with a goal of improving 
its aqueous solubility, dissolution, in vivo bioavailability, 
and antioxidant activity. 
Methods:
Results:
Conclusions
• The prepared APLC demonstrated superior aqueous 
solubility, bioavailability, and antioxidant properties 
when compared to apigenin alone.
• A promising strategy for improved delivery of drugs 
with poor aqueous solubility. 
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Figure 4. Mean plasma concentration-time profile after oral administration of pure apigenin 
(100 mg/kg, p.o.) or APLC (~100 mg/kg apigenin, p.o.). Values are mean ± Std. Dev. (n = 6). 
*p < 0.05; **p < 0.01, and ***p < 0.001 (significant wrt pure apigenin treated group).
Figure 3. Influence of pure apigenin and APLC on rat liver antioxidant marker enzymes, i.e. 
glutathione reductase (GSH) (nmoles/mg of protein), superoxide dismutase (SOD) (units/mg 
protein), catalase (CAT) (units/mg protein), and lipid peroxidase (LPO) (nmoles of MDA 
released /g tissue). Values are Mean ± Std. Error of Mean (n = 6). *p < 0.05, **p < 0.01 
(significant with respect to control: CCl4-only treated groups).
Figure 2. The in-vitro dissolution profiles of apigenin release from apigenin suspension, and 
APLC. Values are mean ± Std. Dev. (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 (significant with 
respect to pure apigenin).
*Data expressed as mean ± Std. Dev.; n = 3
Table 1. Solubility analysis of pure apigenin, the physical mixture (1:1) of apigenin and 
Phospholipon® 90H (PM), and apigenin- Phospholipon® 90H complex (APLC).
Figure 1. The response surface plot and 
contour plots of entrapment efficiency (Y, %) 
as a function of the ratio of apigenin and 
Phospholipon® 90H (X1, w:w), and the reaction 
temperature (X2, °C).
Results:
